Intercell: Sale Is No Longer Ruled Out

Business › n.a. ♦ Published: May 11, 2011; 07:35 ♦ (Vindobona)

The new CEO of the Austrian pharmaceutical company, Thomas Lingelbach intends to implement a new strategy for the company. A sale is possible.

Intercell: Sale Is No Longer Ruled Out / Picture: © Intercell

Intercell had to cope with some severe setbacks last year.  The loss in 2010 was not less than € 255m. The loss will still amount to about € 40m in the present year. Thomas Lingelbach is the new CEO since yesterday, replacing Gerd Zettlmeissl. A new strategy is to be developed before the Annual General Meeting on June 10.

Losses should be gradually reduced in the coming…

or Log In

Fast News Search
Related News
Lingelbach New CEO for Intercell (May 5, 2011)
Intercell starts a confirmatory clinical study using the Vaccine Enhancement (May 4, 2011)
Intercell: Vaccine Development to Suspend (April 11, 2011)
Intercell Announces next Steps of Development for Pseudomonas Vaccine (April 1, 2011)
Read More
Intercell, Thomas Lingelbach, Pharmaceutical Industry, Health Policy, USA, Earnings
Featured
See latest Vindobona Newsletter